Related Experiment Video

Updated: Oct 9, 2026

Polytetrafluoroethylene (PTFE) as a Suture Material in Tendon Surgery

Polytetrafluoroethylene (PTFE) as a Suture Material in Tendon Surgery

Published on: October 6, 2022

Human composite flexor tendon allografts. A report of two cases

G Asencio¹, G Abihaidar, C Leonardi

¹Department of Orthopaedic Surgery, Gaston Doumergue Hospital, Nîmes, France.

Journal of Hand Surgery (Edinburgh, Scotland)

|February 1, 1996

Abstract:

We report two cases in whom human composite flexor tendon allografts were used, and followed-up for more than 5 years. The results show a real improvement in function, without any complications.

More Related Videos

Harvesting of Peroneus Longus Tendon Autograft

Harvesting of Peroneus Longus Tendon Autograft

Published on: September 2, 2025

Vascularized Composite Hand Allograft Procurement and Preparation for Distal and Proximal Forearm Allotransplantation: A Stepwise Approach

Vascularized Composite Hand Allograft Procurement and Preparation for Distal and Proximal Forearm Allotransplantation: A Stepwise Approach

Published on: May 23, 2025

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Electrical Burn Injuries in the United States: Recent Demographic, Clinical, and Regional Patterns from the BCQP Registry.

Journal of burn care & research : official publication of the American Burn Association·2026

Abnormal Forgetting Rate from the Recency Portion of a Word-List in Patients with Subjective Cognitive Decline.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2025

Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.

The British journal of dermatology·2021

A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial.

The British journal of dermatology·2020

Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2).

The British journal of dermatology·2020

Efficacy of risankizumab in patients with moderate-to-severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa-1 and UltIMMa-2 studies.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

See all related articles